181 results on '"Eucker J"'
Search Results
2. Transformation and additional malignancies are leading risk factors for an adverse course of disease in marginal zone lymphoma
3. Metastasiertes Mammakarzinom: Differenzierte, möglichst zielgerichtete medikamentöse Therapie
4. Overall survival in advanced breast cancer is associated with the type of 1st line treatment but not with an objective response to this treatment: ID 442
5. Mammakarzinom bei alten Patientinnen: Stellenwert der adjuvanten Chemotherapie und Radiotherapie
6. Therapie des Mammakarzinoms: Vom Hormon bis zum Antikörper
7. Relationship between bone marrow angiogenesis and plasma cell infiltration and serum β2-microglobulin levels in patients with multiple myeloma
8. Coincidence of Gaucher's disease due to a 1226G/1448C mutation and of an immunoglobulin G lambda multiple myeloma with Bence-Jones proteinuria
9. Patients with malignant lymphomas experience a higher rate of documented infections than patients with breast cancer after high-dose chemotherapy with autologous peripheral stem cell transplantation
10. Bone marrow microvessel density is a prognostic factor for survival in patients with multiple myeloma
11. Disseminated Mucormycosis Caused by Absidia corymbifera Leading to Cerebral Vasculitis
12. New therapeutic approaches in primary systemic AL amyloidosis
13. ERβ2 and ERâ5 inhibit proliferation and promote Tamoxifen-sensitivity in breast cancer cells: V716
14. First results of a phase II study with combined systemic and intrathecal chemotherapy followed by high-dose chemotherapy for CNS relapse of aggressive lymphomas: V649
15. Everolimus in combination with carboplatin: a promising treatment with low toxicity in heavily pretreated metastatic breast cancer: V440
16. ERβ2 and ERβ5 inhibit proliferation and promote Tamoxifen-sensitivity of breast cancer cells: V424
17. Enhancement of TRAIL-induced growth inhibition and apoptosis in human SKBR3 breast cancer cells by retiniods: V54
18. Treatment of refractory chronic lymphocytic leukemia with alemtuzumab (Campath) in chronic hepatitis B infection: P864
19. Expression of “receptor activator of NF-kappa B ligand” (RANKL) mRNA in human multiple myeloma cells: P691
20. Prognostic value of circulating levels of angiogenic cytokines vascular endothelial growth factor, fibroblast growth factor and hepatocyte growth factor in patients with multiple myeloma: V310
21. Rapid reversal of nephrotic syndrome due to primary systemic AL amyloidosis after VAD and subsequent high-dose chemotherapy with autologous stem cell support
22. ICTP serum levels can be used as a surrogate marker for skeletal involvement in multiple myeloma patients lacking osteolytic lesions in conventional radiography: 754
23. A comparison of the clinical applicability of three collagen I degradation products for the evaluation of myeloma-induced bone disease: 260
24. Expression of receptor activator of NF-kappa B ligand (RANKL) by human myeloma cells: 246
25. Decrease of bone marrow angiogenesis in myeloma patients achieving a remission after chemotherapy
26. Retrospective analysis of the treatment of metastatic uveal melanoma comparing systemic chemotherapy and transarterial chemoembolization
27. Limited clinical relevance of imaging techniques in the follow-up of patients with advanced chronic lymphocytic leukemia: results of a meta-analysis
28. Phase 1 study of sorafenib and eribulin in patients with advanced, metastatic or refractory solid tumors
29. 1271P - Retrospective analysis of the treatment of metastatic uveal melanoma comparing systemic chemotherapy and transarterial chemoembolization
30. First results of a phase II study with combined systemic and intrathecal chemotherapy followed by high-dose chemotherapy for CNS relapse of aggressive lymphomas
31. Erstdiagnose einer Autoimmunthrombozytopenie in der Schwangerschaft mit schwerem Verlauf
32. Einfluss der Erst- und Zweitlinientherapie auf das Gesamtüberleben des metastasierten Mammakarzinoms
33. Leitlinienadhärenz beim metastasierten Mammakarzinom
34. 397P - Phase 1 study of sorafenib and eribulin in patients with advanced, metastatic or refractory solid tumors
35. Severe Case of Autoimmune Thrombocytopenia First Diagnosed in Pregnancy
36. Metastasiertes Mammakarzinom
37. Phase II study of central nervous system (CNS)-directed chemotherapy including high-dose chemotherapy with autologous stem cell transplantation for CNS relapse of aggressive lymphomas
38. Individualisierte Therapie des Mammakarzinoms
39. Systemic and intrathecal chemotherapy followed by high-dose chemotherapy with autologous stem cell transplantation (HD-ASCT) for CNS relapse of aggressive lymphomas: A potentially curative approach?
40. Phase I trial with carboplatin and RAD001 in metastatic breast cancer.
41. Klinischer Score zur Prognoseabschätzung beim metastasierten Mammakarzinom
42. Individualisierte Therapie des Mammakarzinoms
43. Diagnostic and Therapeutic Use of Membrane Proteins in Cancer Cells
44. Gastrointestinale Metastasen beim Mammakarzinom
45. Combination of carboplatin and the mTor inhibitor RAD001 is a new therapeutic approach for p53-mutated breast cancer.
46. Association of Borna disease virus infection with depression in cancer patients
47. Systemische Behandlung des Brustkrebses des Mannes
48. Atypical BCR-ABL mRNA transcripts in adult Acute lymphoblastic leukemia
49. Combination of fulvestrant and lapatinib in non-HER2-overexpressing and adriamycin-resistant breast cancer cell lines
50. Therapie des Mammakarzinoms
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.